Matches in Nanopublications for { ?s ?p "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP264955.RANG7PCJ5JVbrYR9vxMfnSMI-PPeGvieWETfCBne-36j0130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP264955.RANG7PCJ5JVbrYR9vxMfnSMI-PPeGvieWETfCBne-36j0130_provenance.
- NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645876.RAf94rcnYilG8Kv--JVoRrSpL4IFuQdlAdzVgC_6gA3V4130_provenance.
- NP442774.RARSDqTxe6Q4s6u0VE296uay74Qt4MDLYysv0_s4fYVHg130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442774.RARSDqTxe6Q4s6u0VE296uay74Qt4MDLYysv0_s4fYVHg130_provenance.
- NP645468.RAmZPmA9HjsrjwcNmi9bDP5YmGLPpF3uQu7CHzQaqmI9Y130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP645468.RAmZPmA9HjsrjwcNmi9bDP5YmGLPpF3uQu7CHzQaqmI9Y130_provenance.
- NP854086.RAIPNvtbu54d9AeO_e68QqmGjhYAz1OVicgnJfPHMt0nw130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP854086.RAIPNvtbu54d9AeO_e68QqmGjhYAz1OVicgnJfPHMt0nw130_provenance.
- NP442770.RAK7bHXFShtLwj_rWFcmhFDV2fIS6CYRzQPIlC7CsulQg130_assertion description "[Activation of JNK1 by anisomycin further increased Tau phosphorylation, and SP600125 (a JNK inhibitor) and PD-98059 (an MEK1/2 inhibitor) blocked Tau phosphorylation and NFT formation in these WOX1 knock-down cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP442770.RAK7bHXFShtLwj_rWFcmhFDV2fIS6CYRzQPIlC7CsulQg130_provenance.